propofol has been researched along with Anomalous Ventricular Excitation Syndrome in 10 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Anesthesia was induced with alfentanil (50 micrograms/kg), midazolam (0." | 9.08 | Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. ( Dobkowski, WB; Klein, G; Murkin, JM; Sharpe, MD; Yee, R, 1995) |
| "We report the anesthetic management using propofol and fentanyl of a patient with concealed Wolff-Parkinson-White syndrome." | 7.70 | [Anesthetic management using propofol and fentanyl of a patient with concealed Wolff-Parkinson-White syndrome]. ( Kitajima, T; Mishio, M; Nagao, M; Okuda, Y; Yamaguchi, S, 1998) |
| "Supraventricular tachycardia was induced in all children receiving propofol, but not induced in 1 and 4 children receiving 0." | 6.87 | Electrophysiological effects of desflurane in children with Wolff-Parkinson-White syndrome: a randomized crossover study. ( Hino, H; Nishikawa, K; Oda, Y; Shimada, M; Suzuki, T; Yoshida, Y, 2018) |
| "The propofol was then replaced with sevoflurane (1 MAC adjusted for age) and the measurements were repeated (EPSsevoflurane)." | 6.73 | [Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome]. ( Bartolomé, FB; Carretero, PS; Fernández, CS; Mateos, EJ; Pérez, ER; Tarlovsky, LG, 2008) |
| " Anesthesia was induced with alfentanil (50 micrograms/kg), midazolam (0." | 5.08 | Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. ( Dobkowski, WB; Klein, G; Murkin, JM; Sharpe, MD; Yee, R, 1995) |
| "We report the anesthetic management using propofol and fentanyl of a patient with concealed Wolff-Parkinson-White syndrome." | 3.70 | [Anesthetic management using propofol and fentanyl of a patient with concealed Wolff-Parkinson-White syndrome]. ( Kitajima, T; Mishio, M; Nagao, M; Okuda, Y; Yamaguchi, S, 1998) |
| "Supraventricular tachycardia was induced in all children receiving propofol, but not induced in 1 and 4 children receiving 0." | 2.87 | Electrophysiological effects of desflurane in children with Wolff-Parkinson-White syndrome: a randomized crossover study. ( Hino, H; Nishikawa, K; Oda, Y; Shimada, M; Suzuki, T; Yoshida, Y, 2018) |
| "Remifentanil may inhibit both intraatrial conduction and sinus node automaticity, but it has no effect on conduction through the atrioventricular node." | 2.76 | High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia. ( Fujii, K; Hatano, Y; Iranami, H; Nakamura, Y, 2011) |
| "The propofol was then replaced with sevoflurane (1 MAC adjusted for age) and the measurements were repeated (EPSsevoflurane)." | 2.73 | [Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome]. ( Bartolomé, FB; Carretero, PS; Fernández, CS; Mateos, EJ; Pérez, ER; Tarlovsky, LG, 2008) |
| "Propofol is a feasible anesthetic for pediatric electrophysiological study and radiofrequency catheter ablation." | 1.35 | Fentanyl added to propofol anesthesia elongates sinus node recovery time in pediatric patients with paroxysmal supraventricular tachycardia. ( Fujii, K; Hatano, Y; Iranami, H; Nakamura, Y, 2009) |
| "Diltiazem was continuously infused at a rate of 0." | 1.31 | [Anesthetic management of MIDCAB in a patient with Wolff-Parkinson-White syndrome]. ( Iwasaki, H; Nagashima, K; Takahata, O; Takayama, K; Yamamoto, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hino, H | 1 |
| Oda, Y | 1 |
| Yoshida, Y | 1 |
| Suzuki, T | 1 |
| Shimada, M | 1 |
| Nishikawa, K | 1 |
| Paech, C | 1 |
| Wagner, F | 1 |
| Strehlow, V | 1 |
| Gebauer, RA | 1 |
| Fujii, K | 2 |
| Iranami, H | 2 |
| Nakamura, Y | 2 |
| Hatano, Y | 2 |
| Pérez, ER | 1 |
| Bartolomé, FB | 1 |
| Carretero, PS | 1 |
| Fernández, CS | 1 |
| Mateos, EJ | 1 |
| Tarlovsky, LG | 1 |
| Wakita, R | 1 |
| Takahashi, M | 1 |
| Ohe, C | 1 |
| Kohase, H | 1 |
| Umino, M | 1 |
| Sharpe, MD | 1 |
| Dobkowski, WB | 1 |
| Murkin, JM | 1 |
| Klein, G | 1 |
| Yee, R | 1 |
| Yamaguchi, S | 1 |
| Nagao, M | 1 |
| Mishio, M | 1 |
| Okuda, Y | 1 |
| Kitajima, T | 1 |
| Seki, S | 1 |
| Ichimiya, T | 1 |
| Tsuchida, H | 1 |
| Namiki, A | 1 |
| Takayama, K | 1 |
| Takahata, O | 1 |
| Yamamoto, Y | 1 |
| Nagashima, K | 1 |
| Iwasaki, H | 1 |
4 trials available for propofol and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Electrophysiological effects of desflurane in children with Wolff-Parkinson-White syndrome: a randomized crossover study.
Topics: Adolescent; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Catheter Ablatio | 2018 |
High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia.
Topics: Action Potentials; Age Factors; Analgesics, Opioid; Anesthetics, Intravenous; Bundle of His; Cathete | 2011 |
[Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome].
Topics: Adolescent; Anesthetics, General; Cardiac Catheterization; Catheter Ablation; Child; Child, Preschoo | 2008 |
Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Topics: Adolescent; Adult; Alfentanil; Anesthesia; Atrioventricular Node; Catheter Ablation; Electrophysiolo | 1995 |
6 other studies available for propofol and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Drug-Induced Loss of Preexcitation in Pediatric Patients with WPW Pattern During Electrophysiologic Study.
Topics: Accessory Atrioventricular Bundle; Adolescent; Anesthesia; Child; Electrocardiography; Electrophysio | 2019 |
Fentanyl added to propofol anesthesia elongates sinus node recovery time in pediatric patients with paroxysmal supraventricular tachycardia.
Topics: Anesthetics, Combined; Anesthetics, Intravenous; Blood Pressure; Catheter Ablation; Child; Electroen | 2009 |
Occurrence of intermittent Wolff-Parkinson-White syndrome during intravenous sedation.
Topics: Anesthetics, Intravenous; Conscious Sedation; Electrocardiography; Epinephrine; Female; Humans; Hype | 2008 |
[Anesthetic management using propofol and fentanyl of a patient with concealed Wolff-Parkinson-White syndrome].
Topics: Anesthesia, Intravenous; Endoscopy; Fentanyl; Humans; Laryngeal Neoplasms; Laryngoscopy; Larynx; Mal | 1998 |
A case of normalization of Wolff-Parkinson-White syndrome conduction during propofol anesthesia.
Topics: Adult; Anesthetics, Intravenous; Electrocardiography; Female; Heart Conduction System; Humans; Propo | 1999 |
[Anesthetic management of MIDCAB in a patient with Wolff-Parkinson-White syndrome].
Topics: Anesthesia, Intravenous; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Fentanyl; Huma | 2000 |